Thromboembolism in gynecologic oncology

Area of Science:

• Gynecologic Oncology
• Vascular Surgery
• Oncology

Background:

• Surgical interventions in gynecologic oncology, particularly lengthy and complex procedures, significantly elevate the risk of thrombo-embolic complications.
• Thrombosis rates in gynecologic operations range from 24-29% without prophylaxis, escalating to nearly 50% in advanced oncological cases.
• Thrombo-embolic events pose serious threats, including difficult-to-treat post-thrombotic syndrome and potentially fatal pulmonary embolism, contributing to postoperative mortality.

Purpose of the Study:

• To highlight the significant risk of thrombo-embolic complications in surgical gynecologic oncology.
• To emphasize the challenges in diagnosing deep vein thrombosis and the importance of preventative measures.
• To advocate for differentiated pharmacological and physical prophylaxis strategies tailored to individual patient needs.

Main Methods:

• Review of existing data on thrombo-embolic complication rates in gynecologic oncology surgeries.
• Discussion of diagnostic modalities for deep vein thrombosis, including phlebography, sounding, and 125-iodine-fibrinogen-testing.
• Consideration of various physical and pharmacological interventions for prevention and treatment.

Main Results:

• High incidence of thrombo-embolic complications in gynecologic oncology, especially in advanced disease and lengthy surgeries.
• Diagnostic uncertainty for deep vein thrombosis even among experienced clinicians.
• Indication for differentiated drug medication and physical means for prevention and therapy.

Conclusions:

• Thrombo-embolic complications are a major concern in surgical gynecologic oncology, necessitating proactive management.
• Accurate diagnosis and individualized prophylaxis strategies are essential to mitigate risks.
• A combination of physical and pharmacological approaches should be considered based on patient-specific factors.